Will ODYSSEY Clear Hurdles for PCSK9 Inhibitor Access?

Drs Budoff and Baum discuss the topline results of the ODYSSEY trial presented at the 2018 ACC meeting and hope for easier access to PCSK9 inhibitors for their high-risk patients.

Source: Medscape Cardiology Podcast - March 22, 2018 Category: Cardiology Authors: Medscape Source Type: podcasts